MP41-03 EXPRESSION OF SOMATOSTATIN RECEPTORS IN PATIENTS WITH ADVANCED BLADDER CANCER IS AN INDICATOR FOR FAVORABLE OUTCOME

Autor:	Jörg Hennenlotter, Tilman Todenhöfer, Marcus Scharpf, Moritz Maas, Simon Walz, Arnulf Stenzl, Tim Neumann, Lisa Rudolph, Ursula Kühs
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Somatostatin receptor business.industry Urology Internal medicine medicine Advanced bladder cancer In patient Favorable outcome business
Zdroj:	Journal of Urology. 199
ISSN:	1527-3792 0022-5347
DOI:	10.1016/j.juro.2018.02.1290
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4a6b492880074ffc5808ab9477bb27bc https://doi.org/10.1016/j.juro.2018.02.1290 Zobrazit plný text záznamu